Timothy Gray - 16 Jan 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Financial Officer
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
16 Jan 2025
Transactions value $
$0
Form type
4
Filing time
21 Jan 2025, 17:26:22 UTC
Previous filing
08 Oct 2024
Next filing
20 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +40,664 $0 40,664 16 Jan 2025 Common Stock 40,664 $27.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.